Marksans Pharma Market Cap

Marksans Pharma has a market cap or net worth of 117.14 billion as of July 1, 2025. Its market cap has increased by 65.07% in one year.

Market Cap

117.14B

Enterprise Value

113.54B

Revenue

26.23B

Ranking

n/a

PE Ratio

30.77

Stock Price

256.95

Market Cap Chart

Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 117.14B, an increase of 3,108.02%. That is a compound annual growth rate of 20.54%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2025	117.14B	-12.86%
Dec 31, 2024	134.43B	84.14%
Dec 29, 2023	73.00B	210.96%
Dec 30, 2022	23.48B	-4.66%
Dec 31, 2021	24.63B	-0.80%
Dec 31, 2020	24.82B	263.17%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,020.57B
Divi's Laboratories	1,807.71B
Cipla	1,216.33B
Apollo Hospitals Enterprise	1,041.29B
Zydus Lifesciences	996.12B
Mankind Pharma	957.45B
Aurobindo Pharma	659.09B
Fortis Healthcare	599.81B

Market Cap Rankings